RNAConnect, a life science company providing next generation tools to the RNA community, today announced the commercial ...

Cell free RNA diagnostics market is projected to reach US$ 204.5 Mn by 2035, expanding at a CAGR of 14.5% from 2025 to 2035 ...

PLAMseq utilizes a rapid biotinylation enzyme called TurboID, which tags nearby proteins, enabling the genomic loci and ...

Global Nanopore Sequencing Market OverviewThe nanopore sequencing market is projected to grow at a CAGR of around 11% during the forecast period, driven by rising demand for real-time, portable DNA ...

Industrialized, small batch, and individual RNA therapeutics become practical with “in-a-box” manufacturing technology.

Innovation in biotech is quickly becoming one of the most important drivers of U.S. competitiveness. As artificial ...

This study provides useful insights into addressing the question of whether the prevalence of autoimmune disease could be driven by sex differences in the T cell receptor (TCR) repertoire, correlating ...

A novel, automated method for manufacturing lung organoids could aid in the discovery of new lung disease therapies.

Researchers say in future it may be possible to grow personalized organoids from patient’s own tissue, to test potential treatments in advance.

The authors provide a useful integrated analytical approach to investigating MASLD focused on diverse multiomic integration methods. The strength of evidence for this new resource is solid, as ...